![Masamichi Sato](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Masamichi Sato served as the Chief Compliance Officer at Santen Pharmaceutical Co., Ltd. from 2018 to 2019.
He also served as the President of Santen Holdings EU BV.
| Unternehmen | Position | Ende |
|---|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Geschäftsführer | 01.10.2016 |
Santen Holdings EU BV
 Santen Holdings EU BV Pharmaceuticals: MajorHealth Technology Operates as an investment holding company whose subsidiaries engages in research, development and marketing of pharmaceuticals | Präsident | 01.04.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Santen Pharmaceutical Co., Ltd.
 Santen Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales prescription drugs & medical devices to treat ophthalmology diseases | Health Technology |
Santen Holdings EU BV
Santen Holdings EU BV Pharmaceuticals: MajorHealth Technology Operates as an investment holding company whose subsidiaries engages in research, development and marketing of pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
